Capsida Biotherapeutics

pause button on blue background
Biotech

Capsida pauses phase 1 gene therapy trial after child dies

AbbVie, CRISPR Therapeutics and Eli Lilly have all struck deals with Capsida.
Nick Paul Taylor Sep 11, 2025 7:30am
White arrow on a road pointing to the rising sun

AbbVie exercises $40M option for Capsida-partnered gene therapy

Jan 7, 2025 10:45am
parachutes peru

Another Biogen exec hitches ride to Voyager —Chutes & Ladders

Mar 15, 2024 9:30am
Los Angeles

VC launches biotech fund with $450M and 'recipe for success'

Jul 17, 2023 12:26pm
layoffs job losses cuts workforce reduction

Capsida cuts staff even with AbbVie, Lilly deals on the books

Jul 14, 2023 12:32pm
eyeball retinal diseases

AbbVie pays $70M to expand Capsida collab into eye disease

Feb 23, 2023 5:00am